Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists

Hèctor Corominas; Ivan Castellví; Pere Domingo; Jordi Casademont

doi:10.5152/eurjrheum.2020.20061

Short Communication

Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists

Volume 7 · Issue 2 Publish Date: April 17, 2020

Hèctor Corominas Ivan Castellví Pere Domingo Jordi Casademont

Full Text

DOI

Published In

European Journal of Rheumatology

Volume 7 · Issue 2

Pages: S107-S109

History

Published Online: April 17, 2020

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright © 2020 European Journal of Rheumatology

Hèctor Corominas

Department of Rheumatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain

Ivan Castellví

Department of Rheumatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain

Pere Domingo

Infectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain

Jordi Casademont

Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain

Corominas, H., Castellví, I., Domingo, P., & Casademont, J. (2020). Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists. European Journal of Rheumatology, 7(2), S107-S109. https://doi.org/10.5152/eurjrheum.2020.20061

Endnote/Zotero/Mendeley (RIS) BibTeX

Full Text

Full Text PDF

Abstract

Cite this article as: Corominas H, Castellví I, Domingo P, Casademont J. Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists. Eur J Rheumatol 2020; 7(Suppl 2): S107-9.

Similar Articles

Article Info

Published In

Journal European Journal of Rheumatology

Volume / Issue Volume 7 · Issue 2

Pages S107-S109

DOI 10.5152/eurjrheum.2020.20061

History

Published Online April 17, 2020

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright

Affiliations

Hèctor Corominas

Department of Rheumatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain

Ivan Castellví

Department of Rheumatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain

Pere Domingo

Infectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain

Jordi Casademont

Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain

Cite this Article

Corominas, H., Castellví, I., Domingo, P., & Casademont, J. (2020). Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists. European Journal of Rheumatology, 7(2), S107-S109. https://doi.org/10.5152/eurjrheum.2020.20061

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Outlines